NEW ORLEANS — Oku Digital Health, which was recently launched from Topcon Healthcare, will use a network of more than 10,000 healthcare locations for early disease detection through routine eye exams, according to a press release.Oculomics is the use of ocular biomarkers to monitor for development of diseases.{{VIDEO}}At the American Academy of Ophthalmology meeting, Ali Tafreshi, CEO of Oku, told Healio that the company’s primary goal is to use this emerging field to address the healthcare cost crisis in the U.S. and globally.“We’ve been planting the seeds for what we call ‘healthcare from